💊 Pharmacology introductory Lesson 2 of 4 4 min read

Drug Routes, Forms & Absorption

The route and form of a medication determine how fast and how completely it is absorbed, shaping onset, duration, and the trade-offs between oral, injected, and other delivery methods.

Reading level

What you'll learn

  • Distinguish enteral from parenteral routes of administration.
  • Compare oral, IV, IM, subcutaneous, topical, inhaled, and sublingual routes by onset and use.
  • Explain how the first-pass effect reduces the bioavailability of oral drugs.
  • Match common drug forms to their purpose and absorption behavior.
  • Weigh the trade-offs between speed of onset and duration of action for different routes.

Overview

A drug can only help if it reaches its target in the right amount at the right speed. The route of administration (where the drug is given) and the drug form (how it is packaged) together control absorption, and therefore the onset and duration of effect. This lesson maps the common routes and forms and the trade-offs among them.

Enteral vs. Parenteral Routes

Routes fall into two broad families:

  • Enteral routes use the gastrointestinal tract — oral, sublingual, and rectal.
  • Parenteral routes bypass the GI tract, usually by injection — intravenous, intramuscular, and subcutaneous. (Topical and inhaled routes are also non-enteral.)

Common Routes at a Glance

RouteWhereOnsetTypical use / note
Oral (PO)SwallowedSlow (30–60 min)Most convenient; subject to first-pass effect
SublingualUnder the tongueFastBypasses first-pass metabolism
Intravenous (IV)Into a veinImmediateEmergencies; 100% bioavailable
Intramuscular (IM)Into muscleModerateMany vaccines; steady absorption
Subcutaneous (SubQ)Under the skin (fat)Slower, sustainedInsulin, some blood thinners
TopicalOn skin/eyesLocal, gradualMostly local effect; some transdermal patches act systemically
InhaledInto the lungsFast (lungs)Respiratory drugs; large surface area

The First-Pass Effect

When a drug is swallowed, it is absorbed from the intestine into the portal vein, which carries it straight to the liver before it reaches the rest of the body. The liver may inactivate a large share of the dose — the first-pass effect. This is why some drugs are ineffective by mouth and are instead given sublingually, by injection, or by patch, all of which enter the circulation without passing through the liver first.

Onset vs. Duration Trade-offs

Fast and long-lasting usually pull in opposite directions:

  • IV acts almost instantly but the entire dose is committed at once — there is little chance to correct an error once it is infused.
  • Oral is slow and convenient, and effects taper gradually.
  • SubQ and depot injections release drug slowly for a prolonged, steady effect.

Choosing a route means balancing how quickly an effect is needed against how long it should last and how convenient and safe the method is for the patient.

Drug Forms

The physical form shapes how quickly a drug dissolves and absorbs.

FormDescription
TabletCompressed powder; must disintegrate and dissolve before absorption
CapsulePowder or liquid inside a gelatin shell
SuspensionFine drug particles dispersed in liquid; shake before use; absorbs quickly
Solution / syrupDrug fully dissolved in liquid; easy to dose for children
Extended-releaseEngineered to release drug slowly for a longer, steadier effect
Ointment / cream / patchSemisolid or transdermal forms for skin application
Aerosol / inhalerDelivers fine mist or powder to the airways

Because a suspension or solution is already dispersed, it is usually absorbed faster than a solid tablet, which first has to break apart and dissolve. Extended-release forms should never be crushed, because doing so can release the whole dose at once.

What Slows or Speeds Absorption

Several factors change how quickly a drug crosses from its site of administration into the blood:

  • Blood flow to the area — a well-perfused site (muscle, lungs) absorbs faster than fatty tissue.
  • Surface area — the huge surface of the small intestine and the lungs favors rapid absorption.
  • Solubility and formulation — dissolved drug is ready to absorb; solids must dissolve first.
  • Presence of food — a full stomach can slow the absorption of many oral drugs.

These same factors explain why the route is such a powerful lever: it places the drug where absorption is fast or slow by design.

Clinical Relevance

Route and form decisions are everyday clinical judgments. An unconscious patient cannot swallow, so a parenteral route is chosen. A person with severe nausea may need a drug given by injection or rectally. Children are often given liquids so the dose can be measured precisely to body weight. Recognizing that inhalers deliver medicine efficiently to the lungs, that patches provide slow steady dosing through the skin, and that IV lines act instantly helps caregivers anticipate how fast a medication will work and how long its effect will last.

Going deeper advanced

Extra depth for when you're ready — expanded automatically in Advanced mode.

Quantifying bioavailability and first pass

Bioavailability (F) is the fraction of an administered dose that reaches systemic circulation in active form, ranging from F = 1.0 for intravenous drugs down to a small fraction for heavily first-pass-metabolized oral drugs. A drug with 30% oral bioavailability needs an oral dose roughly three times its intravenous dose to expose the body to the same amount. Because first-pass extraction occurs in the gut wall and liver, routes that drain into systemic rather than portal veins (sublingual, transdermal, most injections) can bypass it entirely.

Extended-release logic and the blood-brain barrier

Extended-release formulations deliberately slow drug dissolution or diffusion so plasma levels stay within the therapeutic window longer, smoothing the peaks and troughs of immediate-release dosing and improving adherence; crushing them defeats this and can dump a full dose at once. Separately, the blood-brain barrier's tight endothelial junctions and efflux transporters keep many drugs out of the central nervous system. Lipophilic, small, uncharged molecules cross most readily, which is why some agents act centrally while others, by design or by chemistry, remain confined to the periphery.

Key terms

Enteral route
Administration through the gastrointestinal tract, such as oral, sublingual, or rectal routes.
Parenteral route
Administration that bypasses the gastrointestinal tract, most often by injection (IV, IM, or subcutaneous).
Intravenous (IV)
Injection directly into a vein, giving the fastest onset and 100% bioavailability.
Intramuscular (IM)
Injection into a muscle, which absorbs the drug steadily through its rich blood supply.
Subcutaneous (SubQ)
Injection into the fatty tissue beneath the skin, giving slower, more sustained absorption.
Sublingual
Placement of a drug under the tongue so it absorbs directly into blood vessels and bypasses the liver's first pass.
First-pass effect
The loss of active drug as an orally absorbed dose passes through the liver before reaching the general circulation.
Onset of action
The time between administering a drug and the beginning of its noticeable effect.

Check your understanding

6 questions · answers reveal instantly.

  1. 1.Which route generally produces the FASTEST onset of drug action?
  2. 2.The first-pass effect most directly reduces the bioavailability of drugs given by which route?
  3. 3.A nitroglycerin tablet placed under the tongue works quickly partly because it:
  4. 4.Which of the following is an ENTERAL route?
  5. 5.Compared with a tablet, a liquid suspension of the same drug generally:
  6. 6.A key trade-off of the intravenous route is that it:

Citations & References

Links open publicly available educational and peer-reviewed sources.

  1. MedlinePlus, U.S. National Library of Medicine. ↗
  2. MedlinePlus: Drugs, Herbs and Supplements. ↗
  3. Merck Manual. ↗